Trends in Modern Phase 1 Oncology Trials
Condition(s):CancerLast Updated:January 7, 2021Completed
Hide Studies Not Open or Pending
Condition(s):CancerLast Updated:January 7, 2021Completed
Condition(s):Phase 1 Portion : Non Small Cell Lung Cancer(NSCLC), Small Cell Lung Cancer(SCLC), Mesothelioma; Phase 2 Portion : Small Cell Lung Cancer(SCLC)Last Updated:December 15, 2016Terminated
Condition(s):Coronary Artery DiseaseLast Updated:January 13, 2021Completed
Condition(s):Solid Tumors (Phase 1); Relapsed/Recurrent GBM (Phase 2)Last Updated:July 23, 2021Terminated
Condition(s):Non-muscle Invasive Bladder CancerLast Updated:November 30, 2022Recruiting
Condition(s):Superficial Bladder CancerLast Updated:May 13, 2022Recruiting
Condition(s):Prostate CancerLast Updated:January 19, 2023Active, not recruiting
Condition(s):Growth Hormone DeficiencyLast Updated:June 14, 2012Completed
Condition(s):Advanced Solid Tumors; HER2-positive Breast CancerLast Updated:November 21, 2022Recruiting
Condition(s):Glioblastoma; Glioblastoma Multiforme; GliosarcomaLast Updated:August 6, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.